Measles elimination in the United States.

W. Orenstein,M. Papania,M. Wharton

DOI: https://doi.org/10.1086/377693

2004-05-01

Abstract:In 1962, immediately preceding the licensure of the first measles vaccines in the United States, when measles was a nearly universal disease, Alexander Langmuir described the medical importance of measles to the country and put forth the challenge of measles eradication [1]. Although most patients recovered without permanent sequelae, the high number of cases each year made measles a significant cause of serious morbidity and mortality. Langmuir showed that 190% of Americans were infected with the measles virus by age 15 years [1]. This equated to roughly 1 birth cohort (4 million people) infected with measles each year. Not all cases were reported to the public health system; from 1956 to 1960, an average of 542,000 cases were reported annually. By the late 1950s, even before the introduction of measles vaccine, measles-related deaths and case fatality rates in the United States had decreased markedly, presumably as a result of improvement in health care and nutrition. From 1956 to 1960, an average of 450 measles-related deaths were reported each year (∼1 death/ 1000 reported cases), compared with an average of 5300 measles-related deaths during 1912‐1916 (26 deaths/ 1000 reported cases) [2]. Nevertheless, in the late 1950s, serious complications due to measles remained frequent and costly. As a result of measles virus infections, an average of 150,000 patients had respiratory complications and 4000 patients had encephalitis each year; the latter was associated with a high risk of neurological sequelae and death. These complications and others resulted in an estimated 48,000 persons with measles being hospitalized every year [3].